| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |